(1-ethyl-4c-hydroxy-4t-phenyl-[3r]piperidyl)-phenyl ketone | 13721-15-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (1-ethyl-4c-hydroxy-4t-phenyl-[3r]piperidyl)-phenyl ketone
• 英文别名: (1-Aethyl-4c-hydroxy-4t-phenyl-[3r]piperidyl)-phenyl-keton；[(3S,4R)-1-ethyl-4-hydroxy-4-phenylpiperidin-3-yl]-phenylmethanone
• CAS: 13721-15-8
• 化学式: C₂₀H₂₃NO₂
• 分子量: 309.408
• InChiKey: HGHSAQKKTCGYPM-QUCCMNQESA-N

物化性质

• 熔点：
  100-102 °C
• 沸点：
  479.9±45.0 °C(Predicted)
• 密度：
  1.138±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  40.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (1-ethyl-4c-hydroxy-4t-phenyl-[3r]piperidyl)-phenyl ketone 在 氢溴酸 作用下， 生成 2-Ethyl-9-phenyl-2,3-dihydro-1H-indeno[2,1-c]pyridine
  参考文献：
  名称：

  Conformationally-restricted ligands for the histamine H 1 receptor

  摘要：

  Potent H-1-antagonistic activity in a series of novel indeno[2,1-c]pyridines and their 4-arylpiperidinol precursors is reported; one compound shows an in vitro activity four times that of the standard mepyramine that it was screened against. Their Failure to translate this protection to in vivo tests is discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00199-2
• 作为产物：
  描述：

  ethyl-bis-(3-oxo-3-phenyl-propyl)-amine; hydrochloride 在 sodium hydroxide 作用下， 生成 (1-ethyl-4c-hydroxy-4t-phenyl-[3r]piperidyl)-phenyl ketone
  参考文献：
  名称：

  1,3,4-TRISUBSTITUTED PIPERIDINE DERIVATIVES FROM MANNICH BASES

  摘要：

  DOI：

  10.1021/jo01157a022

文献信息

• 1,3,4-TRISUBSTITUTED PIPERIDINE DERIVATIVES FROM MANNICH BASES
  作者：JOHN T. PLATI、ROBERT A. SCHMIDT、WILHELM WENNER

  DOI：10.1021/jo01157a022

  日期：1949.9
• Conformationally-restricted ligands for the histamine H 1 receptor
  作者：Christopher Upton、Richard H. Osborne、Mohammad Jaffar

  DOI：10.1016/s0960-894x(00)00199-2

  日期：2000.6

  Potent H-1-antagonistic activity in a series of novel indeno[2,1-c]pyridines and their 4-arylpiperidinol precursors is reported; one compound shows an in vitro activity four times that of the standard mepyramine that it was screened against. Their Failure to translate this protection to in vivo tests is discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.